CX3CR1 and myalgic encephalomeyelitis/chronic fatigue syndrome: A disruption in the pathway of interactions between fractalkine and CX3CR1 in glia and circulating cells in ME/CFS patients could associate with altered local central nervous system inflammatory responses and, possibly, drive symptomatology.